Rhumbline Advisers Sells 20,946 Shares of Healthcare Realty Trust Incorporated (NYSE:HR)

Rhumbline Advisers trimmed its holdings in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 1.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,054,054 shares of the real estate investment trust's stock after selling 20,946 shares during the quarter. Rhumbline Advisers owned about 0.30% of Healthcare Realty Trust worth $17,866,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HR. Pzena Investment Management LLC bought a new position in shares of Healthcare Realty Trust in the 3rd quarter valued at about $40,392,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Healthcare Realty Trust by 358.2% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,142,110 shares of the real estate investment trust's stock worth $38,879,000 after acquiring an additional 1,674,583 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Healthcare Realty Trust by 289.5% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,552,109 shares of the real estate investment trust's stock valued at $26,308,000 after purchasing an additional 1,153,657 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Healthcare Realty Trust in the 3rd quarter valued at $7,052,000. Finally, Barclays PLC boosted its position in shares of Healthcare Realty Trust by 116.2% in the 3rd quarter. Barclays PLC now owns 722,582 shares of the real estate investment trust's stock worth $13,117,000 after purchasing an additional 388,305 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Scotiabank decreased their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research report on Tuesday. Jefferies Financial Group lowered shares of Healthcare Realty Trust from a "buy" rating to a "hold" rating and cut their target price for the stock from $19.00 to $17.00 in a report on Thursday, January 2nd. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an "overweight" rating to a "neutral" rating and set a $19.00 price target for the company. in a report on Friday, December 20th. StockNews.com raised Healthcare Realty Trust from a "sell" rating to a "hold" rating in a research report on Tuesday. Finally, Wedbush restated an "outperform" rating and set a $16.00 target price on shares of Healthcare Realty Trust in a report on Thursday, February 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $17.20.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Peter F. Sr Lyle, Sr. purchased 10,000 shares of the business's stock in a transaction dated Friday, December 13th. The shares were bought at an average price of $17.21 per share, for a total transaction of $172,100.00. Following the completion of the acquisition, the director now owns 26,576 shares in the company, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.56% of the company's stock.

Healthcare Realty Trust Price Performance

HR stock traded up $0.07 during midday trading on Tuesday, hitting $16.89. The company's stock had a trading volume of 1,735,576 shares, compared to its average volume of 2,410,244. The company's fifty day moving average price is $16.63 and its 200 day moving average price is $17.38. Healthcare Realty Trust Incorporated has a twelve month low of $12.77 and a twelve month high of $18.90. The stock has a market capitalization of $5.98 billion, a P/E ratio of -9.49 and a beta of 0.94.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The company had revenue of $309.77 million during the quarter, compared to analysts' expectations of $303.81 million. During the same quarter last year, the company posted $0.39 EPS. Healthcare Realty Trust's quarterly revenue was down 6.3% compared to the same quarter last year. Equities analysts expect that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.34%. The ex-dividend date is Monday, March 3rd. Healthcare Realty Trust's dividend payout ratio (DPR) is presently -69.66%.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.